Yale Bulletin and Calendar

February 11, 2005|Volume 33, Number 17



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Scientists call for study of
vaccine's impact on shingles

The varicella vaccine is almost 90% effective against chickenpox, but its impact on herpes zoster (shingles) is unknown and needs wider surveillance, wrote School of Medicine researchers in the Feb. 3 New England Journal of Medicine perspective section.

The varicella virus causes both chickenpox and herpes zoster, which occurs when a latent virus in the brain becomes reactivated and causes a painful rash on the skin, leading to severe pain and burning along nerves. Zoster affects people with compromised immune systems, such as the elderly. Since 1995, when the varicella vaccine was first introduced in the United States, it has greatly reduced the number of chickenpox cases and deaths from varicella. The vaccine may also have a key role in preventing zoster.

"Even though it has been shown that the varicella vaccine has had a major impact on the epidemiology of chickenpox in the U.S., we do not know what impact, if any, the widespread use of the varicella vaccine will have on the epidemiology of herpes zoster or shingles -- its incidence, age distribution and severity," says Dr. Marietta Vazquez, an author on the article and assistant professor in the Department of Pediatrics.

Referring to a study in the same issue, Vazquez and co-author Dr. Eugene D. Shapiro, professor in the Departments of Pediatrics and Epidemiology and Public Health at Yale, note that the study shows a significant decline of 66% in mortality due to varicella.

"These findings are relevant because they emphasize the importance of continuing the varicella vaccination program," says Vazquez. "It is possible that the varicella vaccine may be useful in helping prevent zoster if it is administered to elderly persons who have had chickenpox. The long-term effects of universal vaccination on both chickenpox and zoster need to be assessed so that the vaccine policy can be modified, if necessary."

-- By Karen Peart


T H I SW E E K ' SS T O R I E S

Initiative puts summer study abroad in reach of all students

Study: Wider HIV testing could curb spread of disease

Students find harmony mixing science and music

Fleury extends term as dean of engineering

School of Forestry & Environmental Sciences dean delivers . . .

New Peabody exhibit devoted to the world's largest animals

In another Peabody display, guests can see species of plants that are pests

Designer's metal 'Tropical House' will be spotlight of exhibition

Researcher testing acupuncture's effectiveness in easing back pain


DIVINITY SCHOOL NEWS

Studies find that proteins in amniotic fluid are predictor of preterm labor

Renowned computational language expert to deliver Eero Saarinen Lecture

Library's 'Wake the Dream' program honors Yale's first Chinese alumnus

'Video as Advocacy' to be among topics at 'Rebellious Lawyering' event

Scientists find that smoking can impair memory . . .

Scientists call for study of vaccine's impact on shingles

Finland tops latest ranking of environmentally sound nations

'Intimate Partners' author to talk at Jonathan Edwards master's tea

Two authors win YCIAS book prizes

Students' work on behalf of the community supported by Liman Fellowships

Environmental leaders named F&ES visiting fellows for 2005-2006

Yale luminaries to share expertise for LEAP fundraiser

Sharing cultures through performance

Yale Books in Brief

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home